News
Publications about Encapsulation
USING CELLULOSE SULPHATE
Löhr, M., Müller, P., Karle, P., Stange, J., Mitzner, S., Jesnowski, R., Nizze, H., Nebe, B., Liebe, S., Salmons, B. and Günzburg, W.H. (1998) Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450. Gene Therapy 5, 1070-1078
Karle, P., Müller, P., Renz, R., Jesnowski, R., Saller, R.M., von Rombs, K., Nizze, H., Liebe, S., Günzburg, W.H., Salmons, B and Löhr, M. (1998) Intratumour injection of encapsulated cells producing an ifosfamide activating cytochrome P450 for targeted chemotherapy. Adv. Exp. Med. Biol. 451, 97-106
Pelegrin, M., Marin, M., Noël, D., Del Rio, M., Saller, R., Stange, J., Mitzner, S., Günzburg, W.H. and Piechaczyk, M. (1998) Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Therapy 5, 828-834
Pelegrin, M., Noel, D., Marin, M., Bachrach, E., Saller, R.M., Salmons, B. and Piechaczyk, M. (1999) In vivo production of therapeutic antibodies by engineered cells for immunotherapy of cancer and viral diseases. Gene Ther. Mol. Biol. 3, 167-177
Dautzenberg, H., Schuldt, U., Grasnick, G., Karle, P., Müller, P., Löhr, M., Pelegrin, M., Piechaczyk, M., von Rombs, K., Günzburg, W.H., Salmons, B. and Saller, R.M. (1999) Development of cellulose sulphate based polyelectrolyte complex microcapsules for medical applications. (Bioartificial Organs II: Technology, Medicine & Materials. Eds. Hunkeler, D., Prokop, A., Cherrrington, A.D., Rajotte, R. and Sefton, M.) Annu. N.Y. Acad. Sci. 875, 46-63
Löhr, J.M., Bago, Z.T., Bergmeister, H., Ceijka, M., Freund, M., Gelbmann, W., Günzburg, W.H., Hain, J., Hauenstein, K., Henniger, W., Hoffmeyer, A., Karle, P., Kröger, J-C., Liebe, S., Losert, U., Probst, A., Renner, M., Renz, R., Saller, R., Salmons, B., Schuh, M., Wagner, T. and Walter, I. (1999) Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced stage pancreatic carcinoma: phase I/II study. J. Mol. Med. 77, 393-398
Encapsulating Living Cells
AUSTRIA